Neothetics, Inc.
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- 1
- Market Cap
- -
- Website
- http://www.neothetics.com
Clinical Trials
11
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials
Study to Evaluate the Safety and Efficacy of LIPO-202 for the Reduction of Submental Subcutaneous Fat
- First Posted Date
- 2016-12-29
- Last Posted Date
- 2017-10-20
- Lead Sponsor
- Neothetics, Inc
- Target Recruit Count
- 162
- Registration Number
- NCT03005717
- Locations
- 🇺🇸
Clinical Testing of Beverly Hills, Beverly Hills, California, United States
🇺🇸Ablon Skin Institute And Research Center, Manhattan Beach, California, United States
🇺🇸AboutSkin Research, Greenwood Village, Colorado, United States
Safety and Efficacy Study of LIPO-202 for the Reduction of Central Abdominal Bulging in Obese Subjects
- First Posted Date
- 2015-10-05
- Last Posted Date
- 2015-12-24
- Lead Sponsor
- Neothetics, Inc
- Target Recruit Count
- 120
- Registration Number
- NCT02568319
- Locations
- 🇺🇸
Diagnamics, Inc., Encinitas, California, United States
🇺🇸Ablon Skin Institute and Research Center, Manhattan Beach, California, United States
🇺🇸The Center for Clinical & Cosmetic Research, Aventura, Florida, United States
An Open-Label Study to Evaluate Retreatment With LIPO-202
- First Posted Date
- 2015-03-25
- Last Posted Date
- 2015-08-13
- Lead Sponsor
- Neothetics, Inc
- Target Recruit Count
- 150
- Registration Number
- NCT02397525
- Locations
- 🇺🇸
AboutSkin Dermatology, Englewood, Colorado, United States
🇺🇸Dermatology Research Institute, LLC, Coral Gables, Florida, United States
🇺🇸Gwinnett Clinical Research Center, Inc, Snellville, Georgia, United States
Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat
- First Posted Date
- 2015-03-25
- Last Posted Date
- 2016-01-08
- Lead Sponsor
- Neothetics, Inc
- Target Recruit Count
- 800
- Registration Number
- NCT02397499
- Locations
- 🇺🇸
WG Clinical Research, Tucson, Arizona, United States
🇺🇸Burke Pharmaceutical Research, Hot Springs, Arkansas, United States
🇺🇸Clinical Testing Center of Beverly Hills, Beverly Hills, California, United States
Dose Ranging Study
- Conditions
- Periumbilical Subcutaneous Adipose Tissue Reduction
- First Posted Date
- 2013-03-01
- Last Posted Date
- 2015-03-26
- Lead Sponsor
- Neothetics, Inc
- Target Recruit Count
- 472
- Registration Number
- NCT01802723
- Locations
- 🇺🇸
United States, California, Santa Ana, California, United States
🇺🇸United States, Florida, Tampa, Florida, United States
🇺🇸United States, Illinois, Chicago, Illinois, United States
- Prev
- 1
- 2
- 3
- Next